ACADIA Pharmaceuticals (ACAD) Earnings Date, Estimates & Call Transcripts → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free acad Stock Alerts $18.34 +0.14 (+0.77%) (As of 11:46 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 27) $0.28 Missed By -$0.04 Consensus EPS (Feb. 27) $0.32 Read Call TranscriptListen to Call Get ACADIA Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACAD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACAD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACAD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ACADIA Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.01)$0.12$0.06 Q2 20243$0.18$0.26$0.21 Q3 20243$0.17$0.27$0.22 Q4 20243$0.18$0.33$0.24 FY 202411$0.52$0.98$0.73 Q1 20251$0.30$0.30$0.30 Q2 20251$0.22$0.22$0.22 Q3 20251$0.21$0.21$0.21 Q4 20251$0.21$0.21$0.21 FY 20254$0.94$0.94 $0.94ACAD Earnings Date and InformationACADIA Pharmaceuticals last announced its earnings results on February 27th, 2024. The biopharmaceutical company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.32 by $0.04. The company earned $231.04 million during the quarter, compared to analysts' expectations of $223.79 million. Its quarterly revenue was up 69.3% on a year-over-year basis. ACADIA Pharmaceuticals has generated ($0.38) earnings per share over the last year (($0.38) diluted earnings per share). Earnings for ACADIA Pharmaceuticals are expected to grow by 84.38% in the coming year, from $0.64 to $1.18 per share. ACADIA Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More ACADIA Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/27/2024Q4 2023$0.32$0.28($0.04)$0.28$223.79 million$231.04 million 11/2/2023Q3 2023($0.43)($0.40)+$0.03($0.40)$194.40 million$211.70 million8/2/2023Q2 2023($0.12)$0.01+$0.13$0.01$163.86 million$165.20 million 5/8/2023Q1 2023($0.21)($0.27)($0.06)($0.27)$120.29 million$118.46 million 2/27/2023Q4 2022($0.25)($0.26)($0.01)($0.26)$135.18 million$136.49 million 11/2/2022Q3 2022($0.18)($0.17)+$0.01($0.17)$139.04 million$130.70 million Get the Latest News and Ratings for ACAD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.25)($0.21)+$0.04($0.21)$130.06 million$134.56 million 5/4/2022Q1 2022($0.49)($0.70)($0.21)($0.70)$122.22 million$115.47 million 2/28/2022Q4 2021($0.24)($0.27)($0.03)($0.27)$135.44 million$130.80 million 11/8/2021Q3 2021($0.26)($0.09)+$0.17($0.09)$127.77 million$131.61 million 8/3/2021Q2 2021($0.30)($0.27)+$0.03($0.27)$124.94 million$115.22 million 5/4/2021Q1 2021($0.53)($0.42)+$0.11($0.42)$112.91 million$106.55 million ACADIA Pharmaceuticals Earnings - Frequently Asked Questions When is ACADIA Pharmaceuticals's earnings date? ACADIA Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on ACAD's earnings history. Did ACADIA Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ACADIA Pharmaceuticals (NASDAQ:ACAD) missed the analysts' consensus estimate of $0.32 by $0.04 with a reported earnings per share (EPS) of $0.28. Learn more on analysts' earnings estimate vs. ACAD's actual earnings. How can I listen to ACADIA Pharmaceuticals's earnings conference call? The conference call for ACADIA Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read ACADIA Pharmaceuticals's conference call transcript? The conference call transcript for ACADIA Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does ACADIA Pharmaceuticals generate each year? ACADIA Pharmaceuticals (NASDAQ:ACAD) has a recorded annual revenue of $726.44 million. How much profit does ACADIA Pharmaceuticals generate each year? ACADIA Pharmaceuticals (NASDAQ:ACAD) has a recorded net income of -$61.29 million. ACAD has generated -$0.38 earnings per share over the last four quarters. What is ACADIA Pharmaceuticals's EPS forecast for next year? ACADIA Pharmaceuticals's earnings are expected to grow from $0.64 per share to $1.18 per share in the next year, which is a 84.38% increase. More Earnings Resources from MarketBeat Related Companies: Crinetics Pharmaceuticals Earnings Date MoonLake Immunotherapeutics Earnings Date Arvinas Earnings Date Indivior Earnings Date IDEAYA Biosciences Earnings Date Xenon Pharmaceuticals Earnings Date MorphoSys Earnings Date Bausch Health Companies Earnings Date Arrowhead Pharmaceuticals Earnings Date Amicus Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:ACAD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.